Skip to main content
$1.64 -$0.02 (-1.2%)

04:00 PM EDT on 09/26/23

Protalix Biotherapeutics Inc (NYSEMKT:PLX)

CAPS Rating: No stars

A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system.

Current Price $1.64 Mkt Cap $117.4M
Open $1.66 P/E Ratio 135.54
Prev. Close $1.64 Div. (Yield) $0.00 (0.0%)
Daily Range $1.63 - $1.67 Volume 1
52-Wk Range $1.00 - $3.55 Avg. Daily Vol. 755,011

Caps

How do you think NYSEMKT:PLX will perform against the market?

Add Stock to CAPS Watchlist

All Players

147 Outperform
72 Underperform
 

All-Star Players

10 Outperform
23 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSEMKT:PLX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Paul8888888 (< 20)
Submitted January 23, 2016

It is outperforming the market. Volume low. Nobody is panicking.

TMFBiologyFool (68.78)
Submitted May 02, 2012

Low patient numbers + 2 competitors = tough launch.I actually like the manufacturing technology, but next drug is still years away.

Fools bullish on NYSEMKT:PLX are also bullish on:

Fools bearish on NYSEMKT:PLX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about PLX.

Recs

1
Member Avatar Paul8888888 (< 20) Submitted: 1/23/2016 2:31:12 PM : Outperform Start Price: $0.86 NYSE MKT:PLX Score: -35.33

It is outperforming the market. Volume low. Nobody is panicking.

Recs

0
Member Avatar SqwiiTrader (< 20) Submitted: 11/5/2013 2:56:24 PM : Outperform Start Price: $4.40 NYSE MKT:PLX Score: -203.91

IHS pattern

Recs

2
Member Avatar TMFBiologyFool (68.78) Submitted: 5/2/2012 12:24:24 PM : Underperform Start Price: $7.02 NYSE MKT:PLX Score: +280.32

Low patient numbers + 2 competitors = tough launch.

I actually like the manufacturing technology, but next drug is still years away.

Leaderboard

Find the members with the highest scoring picks in PLX.

Score Leader

midastouch017

midastouch017 (< 20) Score: +734.62

For those who believe the biosimilar sector will enjoy a robust bright future, PLX is a wise bet

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
1or5stars 98.32 2/10/2009 Underperform 3W $2.66 -38.35% +402.36% +440.71 0 Comment
anticitradeshort 28.16 4/20/2009 Underperform NS $2.27 -27.75% +403.06% +430.81 0 Comment
Spelunkin 26.51 11/3/2009 Underperform 5Y $10.39 -84.22% +310.53% +394.74 0 Comment
anticitrademix2 < 20 11/2/2009 Underperform 5Y $9.90 -83.43% +308.99% +392.42 0 Comment
anticitrademix < 20 11/2/2009 Underperform 5Y $9.90 -83.43% +308.99% +392.42 0 Comment
MSFOBV1YH 96.36 11/4/2009 Underperform 5Y $10.93 -85.00% +303.64% +388.63 0 Comment
ModernDayWarrior 32.35 10/29/2009 Underperform 5Y $9.58 -82.88% +304.87% +387.75 0 Comment
TrackDuality < 20 11/6/2009 Underperform 5Y $11.89 -86.21% +300.79% +387.00 0 Comment
mathieugp 44.17 9/28/2009 Underperform 3M $7.87 -79.16% +306.18% +385.34 0 Comment
39272x4 22.31 11/9/2009 Underperform 5Y $12.00 -86.33% +294.52% +380.85 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PLX.